October 6, 2026StocksTechnology·Neutral·biotech
BridgeBio to present additional Phase 3 encaleret data in genetic hypocalcemia ADH1 at ASBMR on October 11
BridgeBio announced it will present additional Phase 3 encaleret data in genetic hypocalcemia ADH1 at the ASBMR meeting on October 11.
Detected & updated continuously · Source: Nebula
Story subjects
BridgeBioencaleret